MazF6 toxin of Mycobacterium tuberculosis demonstrates antitoxin specificity and is coupled to regulation of cell growth by a Soj-like protein

BMC Microbiology

Volumn 13, Issue 1, 2013, Pages

  Ramirez, Melissa V ^a   Dawson, Clinton C ^a   Crew, Rebecca ^a,c   England, Kathleen ^a,b   Slayden, Richard A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Cell cycle; MazF; Mycobacterium tuberculosis; So jMtb; Toxin:antitoxin

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; GENOMIC DNA; MAZE6 TOXIN; MAZF6 TOXIN; MESSENGER RNA; SOJ LIKE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERIOSTASIS; CELL CYCLE REGULATION; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG; MACROPHAGE; MOUSE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POLYMERIZATION; SPLEEN; UPREGULATION; WESTERN BLOTTING;

MYCOBACTERIUM TUBERCULOSIS;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL TOXINS; CELL CYCLE; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; SEQUENCE ALIGNMENT;

EID: 84886734378     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-13-240     Document Type: Article

References (52)

1. Dormancy of mycobacterium tuberculosis and latency of disease. Wayne LG, Eur J Clin Microbiol Infect Dis 1994 13 11 908 914 10.1007/BF02111491 7698116
2. Mycobacterium tuberculosis cells growing in macrophages are filamentous and deficient in FtsZ rings. Chauhan A, Madiraju MV, Fol M, Lofton H, Maloney E, Reynolds R, Rajagopalan M, J Bacteriol 2006 188 5 1856 1865 10.1128/JB.188.5.1856-1865.2006 16484196 (Pubitemid 43346864)
3. An in vitro model for sequential study of shiftdown of mycobacterium tuberculosis through two stages of nonreplicating persistence. Wayne LG, Hayes LG, Infect Immun 1996 64 6 2062 2069 8675308 (Pubitemid 26165667)
4. Identification of cell cycle regulators in mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis. Slayden RA, Knudson DL, Belisle JT, Microbiology 2006 152 Pt 6 1789 1797 16735741
5. Characterizing septum inhibition in mycobacterium tuberculosis for novel drug discovery. Respicio L, Nair PA, Huang Q, Anil B, Tracz S, Truglio JJ, Kisker C, Raleigh DP, Ojima I, Knudson DL, et al. Tuberculosis (Edinb) 2008 88 5 420 429 10.1016/j.tube.2008.03.001 18479968
6. Mycobacterium tuberculosis septum site determining protein, Ssd encoded by rv3660c, promotes filamentation and elicits an alternative metabolic and dormancy stress response. England K, Crew R, Slayden RA, BMC Microbiol 2011 11 79 10.1186/1471-2180-11-79 21504606
7. sfi-independent filamentation in Escherichia coli Is lexA dependent and requires DNA damage for induction. Hill TM, Sharma B, Valjavec-Gratian M, Smith J, J Bacteriol 1997 179 6 1931 1939 9068638 (Pubitemid 27123075)
8. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Goh EB, Yim G, Tsui W, McClure J, Surette MG, Davies J, Proc Natl Acad Sci USA 2002 99 26 17025 17030 10.1073/pnas.252607699 12482953 (Pubitemid 36034092)
9. Identification of a protein, YneA, responsible for cell division suppression during the SOS response in Bacillus subtilis. Kawai Y, Moriya S, Ogasawara N, Mol Microbiol 2003 47 4 1113 1122 10.1046/j.1365-2958.2003.03360.x 12581363 (Pubitemid 36232805)
10. Heat and DNA damage induction of the LexA-like regulator HdiR from lactococcus lactis is mediated by RecA and ClpP. Savijoki K, Ingmer H, Frees D, Vogensen FK, Palva A, Varmanen P, Mol Microbiol 2003 50 2 609 621 10.1046/j.1365-2958.2003.03713.x 14617183 (Pubitemid 37297138)
11. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H, Cohen SN, Science 2004 305 5690 1629 1631 10.1126/science.1101630 15308764 (Pubitemid 39296359)
12. Filamentation by escherichia coli subverts innate defenses during urinary tract infection. Justice SS, Hunstad DA, Seed PC, Hultgren SJ, Proc Natl Acad Sci USA 2006 103 52 19884 19889 10.1073/pnas.0606329104 17172451 (Pubitemid 46037525)
13. Interference of mycobacterium tuberculosis cell division by Rv2719c, a cell wall hydrolase. Chauhan A, Lofton H, Maloney E, Moore J, Fol M, Madiraju MV, Rajagopalan M, Mol Microbiol 2006 62 1 132 147 10.1111/j.1365-2958.2006. 05333.x 16942606 (Pubitemid 44386555)
14. Complete and SOS-mediated response of staphylococcus aureus to the antibiotic ciprofloxacin. Cirz RT, Jones MB, Gingles NA, Minogue TD, Jarrahi B, Peterson SN, Romesberg FE, J Bacteriol 2007 189 2 531 539 10.1128/JB.01464-06 17085555 (Pubitemid 46106385)
15. Morphological plasticity as a bacterial survival strategy. Justice SS, Hunstad DA, Cegelski L, Hultgren SJ, Nat Rev Microbiol 2008 6 2 162 168 10.1038/nrmicro1820 18157153
16. Morphological features and signature gene response elicited by inactivation of FtsI in mycobacterium tuberculosis. Slayden RA, Belisle JT, J Antimicrob Chemother 2009 63 3 451 457 10.1093/jac/dkn507 19109339
17. Updating and curating metabolic pathways of TB. Slayden RA, Jackson M, Zucker J, Ramirez MV, Dawson CC, Crew R, Sampson NS, Thomas ST, Jamshidi N, Sisk P, et al. Tuberculosis 2013 93 1 47 59 10.1016/j.tube.2012.11.001 23375378
18. Prokaryotic toxin-antitoxin stress response loci. Gerdes K, Christensen SK, Lobner-Olesen A, Nat Rev Microbiol 2005 3 5 371 382 10.1038/nrmicro1147 15864262 (Pubitemid 40590380)
19. Bacterial persistence and toxin-antitoxin loci. Gerdes K, Maisonneuve E, Annu Rev Microbiol 2012 66 103 123 10.1146/annurev-micro-092611-150159 22994490
20. Comprehensive functional analysis of mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. Ramage HR, Connolly LE, Cox JS, PLoS Genet 2009 5 12 1000767 10.1371/journal.pgen.1000767 20011113
21. Characterization and transcriptome analysis of mycobacterium tuberculosis persisters. Keren I, Minami S, Rubin E, Lewis K, MBio 2011 2 3 00100 00111 21673191
22. Toxin-antitoxin systems in bacteria and archaea. Yamaguchi Y, Park JH, Inouye M, Annu Rev Genet 2011 45 61 79 10.1146/annurev-genet-110410-132412 22060041
23. Proteomic profiling of mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems. Albrethsen J, Agner J, Piersma SR, Hojrup P, Pham TV, Weldingh K, Jimenez CR, Andersen P, Rosenkrands I, Mol Cell Proteomics 2013 12 5 1180 1191 10.1074/mcp.M112.018846 23345537
24. TB database 2010: overview and update. Galagan JE, Sisk P, Stolte C, Weiner B, Koehrsen M, Wymore F, Reddy TB, Zucker JD, Engels R, Gellesch M, et al. Tuberculosis (Edinb) 2010 90 4 225 235 10.1016/j.tube.2010.03.010 20488753
25. Functional genetic diversity among mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. Homolka S, Niemann S, Russell DG, Rohde KH, PLoS Pathog 2010 6 7 1000988 10.1371/journal.ppat.1000988 20628579
26. TB database: an integrated platform for tuberculosis research. Reddy TB, Riley R, Wymore F, Montgomery P, DeCaprio D, Engels R, Gellesch M, Hubble J, Jen D, Jin H, Nucleic Acids Res 2009 37 Database issue 499 508 18835847
27. Genetic requirements for the survival of tubercle bacilli in primates. Dutta NK, Mehra S, Didier PJ, Roy CJ, Doyle LA, Alvarez X, Ratterree M, Be NA, Lamichhane G, Jain SK, et al. J Infect Dis 2010 201 11 1743 1752 10.1086/652497 20394526
28. The genetic requirements for fast and slow growth in mycobacteria. Beste DJ, Espasa M, Bonde B, Kierzek AM, Stewart GR, McFadden J, PLoS One 2009 4 4 5349 10.1371/journal.pone.0005349 19479006
29. Characterization of a Clp protease gene regulator and the reaeration response in mycobacterium tuberculosis. Sherrid AM, Rustad TR, Cangelosi GA, Sherman DR, PLoS One 2010 5 7 11622 10.1371/journal.pone.0011622 20661284
30. Mycobacterial toxin MazF-mt6 inhibits translation through cleavage of 23S rRNA at the ribosomal a site. Schifano JM, Edifor R, Sharp JD, Ouyang M, Konkimalla A, Husson RN, Woychik NA, Proc Natl Acad Sci USA 2013 110 21 8501 8506 10.1073/pnas.1222031110 23650345
31. Classification and evolution of P-loop GTPases and related ATPases. Leipe DD, Wolf YI, Koonin EV, Aravind L, J Mol Biol 2002 317 1 41 72 10.1006/jmbi.2001.5378 11916378 (Pubitemid 34722199)
32. Bacterial chromosome segregation: structure and DNA binding of the Soj dimer-a conserved biological switch. Leonard TA, Butler PJ, Lowe J, Embo J 2005 24 2 270 282 10.1038/sj.emboj.7600530 15635448 (Pubitemid 40216132)
33. Overproduction and localization of mycobacterium tuberculosis ParA and ParB proteins. Maloney E, Madiraju M, Rajagopalan M, Tuberculosis 2009 89 Suppl 1 65 69 20006309
34. Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents. Huang Q, Kirikae F, Kirikae T, Pepe A, Amin A, Respicio L, Slayden RA, Tonge PJ, Ojima I, J Med Chem 2006 49 2 463 466 10.1021/jm050920y 16420032 (Pubitemid 43157479)
35. Assembly dynamics of the bacterial cell division protein FTSZ: poised at the edge of stability. Romberg L, Levin PA, Annu Rev Microbiol 2003 57 125 154 10.1146/annurev.micro.57.012903.074300 14527275 (Pubitemid 37392938)
36. The sigma factors of mycobacterium tuberculosis: regulation of the regulators. Sachdeva P, Misra R, Tyagi AK, Singh Y, Febs J 2010 277 3 605 626 10.1111/j.1742-4658.2009.07479.x 19951358
37. Characterization of mRNA interferases from mycobacterium tuberculosis. Zhu L, Zhang Y, Teh JS, Zhang J, Connell N, Rubin H, Inouye M, J Biol Chem 2006 281 27 18638 18643 10.1074/jbc.M512693200 16611633 (Pubitemid 44035523)
38. The enduring hypoxic response of mycobacterium tuberculosis. Rustad TR, Harrell MI, Liao R, Sherman DR, PLoS One 2008 3 1 1502 10.1371/journal.pone. 0001502 18231589 (Pubitemid 351827196)
39. The decay of the chromosomally encoded ccdO157 toxin-antitoxin system in the escherichia coli species. Mine N, Guglielmini J, Wilbaux M, Van Melderen L, Genetics 2009 181 4 1557 1566 10.1534/genetics.108.095190 19189956
40. Is mycobacterium tuberculosis stressed out? a critical assessment of the genetic evidence. Stallings CL, Glickman MS, Microbes Infect 2010 12 14-15 1091 1101 20691805
41. Immune response to mycobacterium tuberculosis and identification of molecular markers of disease. Gonzalez-Juarrero M, Kingry LC, Ordway DJ, Henao-Tamayo M, Harton M, Basaraba RJ, Hanneman WH, Orme IM, Slayden RA, Am J Respir Cell Mol Biol 2009 40 4 398 409 10.1165/rcmb.2008-0248OC 18787176
42. Transcriptional cross-activation between toxin-antitoxin systems of escherichia coli. Kasari V, Mets T, Tenson T, Kaldalu N, BMC Microbiol 2013 13 45 10.1186/1471-2180-13-45 23432955
43. Three mycobacterium tuberculosis Rel toxin-antitoxin modules inhibit mycobacterial growth and are expressed in infected human macrophages. Korch SB, Contreras H, Clark-Curtiss JE, J Bacteriol 2009 191 5 1618 1630 10.1128/JB.01318-08 19114484
44. Dynamic control of the DNA replication initiation protein DnaA by Soj/ParA. Murray H, Errington J, Cell 2008 135 1 74 84 10.1016/j.cell.2008.07. 044 18854156
45. Inhibition of respiration by nitric oxide induces a mycobacterium tuberculosis dormancy program. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK, J Exp Med 2003 198 5 705 713 10.1084/jem.20030205 12953092 (Pubitemid 37087770)
46. Hypoxia: a window into mycobacterium tuberculosis latency. Rustad TR, Sherrid AM, Minch KJ, Sherman DR, Cell Microbiol 2009 11 8 1151 1159 10.1111/j.1462-5822.2009.01325.x 19388905
47. M. Tuberculosis gene expression during transition to the "Non-culturable" state. Salina EG, Mollenkopf HJ, Kaufmann SH, Kaprelyants AS, Acta Nat 2009 1 2 73 77
48. Letting sleeping dos lie: does dormancy play a role in tuberculosis? Chao MC, Rubin EJ, Annu Rev Microbiol 2010 64 293 311 10.1146/annurev.micro.112408. 134043 20825351
49. Noncognate mycobacterium tuberculosis toxin-antitoxins can physically and functionally interact. Zhu L, Sharp JD, Kobayashi H, Woychik NA, Inouye M, J Biol Chem 2010 285 51 39732 39738 10.1074/jbc.M110.163105 20876537
50. New use of BCG for recombinant vaccines. Stover CK, De la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, et al. Nature 1991 351 6326 456 460 10.1038/351456a0 1904554 (Pubitemid 21896614)
51. Methylation of GPLs in mycobacterium smegmatis and mycobacterium avium. Jeevarajah D, Patterson JH, Taig E, Sargeant T, McConville MJ, Billman-Jacobe H, J Bacteriol 2004 186 20 6792 6799 10.1128/JB.186.20.6792-6799.2004 15466031 (Pubitemid 39332117)
52. Spontaneous cAMP-dependent derepression of gene expression in stationary phase plays a role in recombinant expression instability. Grossman TH, Kawasaki ES, Punreddy SR, Osburne MS, Gene 1998 209 1-2 95 103 9524234 (Pubitemid 28149625)